Antimutagenicity of milk fermented by Enterococcus fœcium

Folia Microbiologica

Volumn 44, Issue 5, 1999, Pages 513-518

  Belicova A ^a   Krajcovic J ^a   Dobias, J ^a   Ebringer, L ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; EUGLENA GRACILIS; MASTIGOPHORA (FLAGELLATES); PHTHIRAPTERA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

ACRYLIC ACID DERIVATIVE; ANTIMUTAGENIC AGENT; METHYLNITRONITROSOGUANIDINE; NITROFURAN DERIVATIVE; NITROFURYLACRYLIC ACID; NITROVIN;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; ENTEROCOCCUS FAECIUM; EUGLENA GRACILIS; FERMENTATION; METABOLISM; MILK; MUTAGENESIS; SALMONELLA TYPHIMURIUM; ULTRAVIOLET RADIATION;

ACRYLATES; ANIMALS; ANTIMUTAGENIC AGENTS; ENTEROCOCCUS FAECIUM; EUGLENA GRACILIS; FERMENTATION; METHYLNITRONITROSOGUANIDINE; MILK; MUTAGENESIS; NITROFURANS; NITROVIN; SALMONELLA TYPHIMURIUM; ULTRAVIOLET RAYS;

EID: 0033288250     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02816252     Document Type: Article

References (24)

1. AGERBAEK M., GERDES L.U., RICHELSEN B.: Hypocholesterolæmic effect of a new fermented milk product in healthy middle-aged men. Eur. J. Clin. Nutr. 49, 346-352 (1995).
2. EBRINGER L.: Interaction of drugs with extracellular genetic elements and its consequences. Teratogen. Carcinogen. Mutagen. 10, 477-501 (1990).
3. EBRINGER L., POLÓNYI J., KRAJČOVIČ J.: Influence of ofloxacin on chloroplasts and mitochondria in Euglena gracilis. Drug Res. 43, 777-781 (1993).
4. EBRINGER L., FERENČÍK M., LAHITOVÁ N., KAČÁNI L., MICHÁLKOVÁ D.: Anti-mutagenic and immuno-stimulatory properties of lactic acid bacteria. World J. Microbiol. Biotechnol. 11, 294-298 (1995).
5. FOLTINOVÁ P., LAHITOVÁ N., EBRINGER L.: Antimutagenicity in Euglena gracilis. Mutat. Res. 323, 167-171 (1994).
6. FOLTINOVÁ P., GRONES J.: Euglena gracilis as an eukaryotic test organism for detecting mutagens and antimutagens. Mutat. Res. 393, 1-6 (1997).
7. HOSODA M., HASHIMOTO H., MORITA H., CHIBA M., HOSONO A.: Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N′-nitro-N-nitrosoguanidine. J. Dairy Sci. 75, 976-981 (1992a).
8. HOSODA M., HASHIMOTO H., MORITA H., CHIBA M., HOSONO A.: Studies on antimutagenic effect of milk cultured with lactic acid bacteria on the Trp-P2-induced mutagenicity to TA98 strain of Salmonella typhimurium. J. Dairy Res. 59, 543-549 (1992b).
9. HOSODA M., HASHIMOTO H., HE F., YAMAZAKI K., HOSONO A.: Inhibitory effect of milk cultured with Lactobacillus strains on the aflatoxin mutagenicity. Animal Sci.Technol. 68, 555-562 (1997).
10. HOSONO A., SHIRAI H.: Antimutagenicity of milk cultured with lactic bacteria against the heated solution of cysteine-glucose. Animal Sci.Technol. 67, 1076-1081 (1996).
11. LOGUERCIO C., ABBIATI R., RINALDI M., ROMANO A., BLANCO C.V., COLTORTI M.: Long-term effects of Enterococcus fœcuim SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J. Hepatol. 23, 39-46 (1995).
12. MARON D.M., AMES B.N.: Revised methods for the Salmonella mutagenicity test. Mutat. Res. 143, 173-215 (1983).
13. MATAR C., NADATHUR S.S., BAKALINSKY A.T., GOULET J.: Antimutagenic effects of milk fermented by Lactobacillus helveticus L89 and a protease-deficient derivative. J. Dairy Sci. 80, 1965-1970 (1997).
14. MIKEŠ Z., FERENČÍK M., JAHNOVÁ Z., EBRINGER L., ČIŽNÁR I.: Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus fœcium M-74 in man. Folia Microbiol. 40, 639-646 (1995).
15. NADATHUR S.R., GOULD S.J., BAKALINSKY A.T.: Antimutagenicity of fermented milk. J. Dairy Sci. 77, 3287-3295 (1994).
16. NADATHUR S.R., GOULD S.J., BAKALINSKY A.T.: Antimutagenicity of an acetone extract of yogurt. Mutat. Res. 334, 213-224 (1995).
17. OLASUPO NA.: Inhibition of Listeria monocytogenes by plantaricin NA, an antibacterial substance from Lactobacillus plantarum. Folia Microbiol. 43, 151-154 (1998).
18. POOL-ZOBEL B.L., BERTRAM B., KNOLL M., LAMBERTZ R., NEUDECKER C., SCHILLINGER U., SCHMEZER P., HOLZAPFEL W.H.: Antigenotoxic properties of lactic acids bacteria in vivo in the gastrointestinal tract of rats. Nutr. Cancer 20, 271-281 (1993).
19. POOL-ZOBEL B.L., MÜNZNER R., HOLZAPFEL W.H.: Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay. Nutr. Cancer 20, 261-270 (1993).
20. POOL-ZOBEL B.L., NEUDECKER C., DOMIZLAFF I., JI S., SCHILLINGER U., RUMNEY C., MORETTI M., VILARINI I., SCASSELLATI-SFORZOLINI R., ROWLAND I.: Lactobacillus and bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer 26, 365-380 (1996).
21. REDDY B.S., RIVENSON A.: Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methyl-imidazo[4,5f]quinoline, and food mutagen. Cancer Res. 53, 3914-3918 (1993).
22. RICE L.J., CHAI Y.J., CONTI C.J., WILLIS R.A., LOCNISKAR M.F.: The effect of dietary fermented milk products and lactic acid bacteria on the initiation and promotion stages of mammary carcinogenesis. Nutr.Cancer 24, 99-109 (1995).
23. RICHELSEN B., AGERBAEK M., GERDES L.U.: Cholesterol-lowering effect of a new fermented milk product in healthy 44-year old Danish men. Ugeskr.Lœger 20, 3015-3019 (1993).
24. RICHELSEN B., KRISTENSEN K., PEDERSEN S.B.: Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double blind study. Eur. J. Clin. Nutr. 50, 811-815 (1996).